LibyaMed

. . Zorgani A, Almagatef A, Sufya N, Bashein A, Tubbal A. . Oman Med J. 2017 Jul;32(4):322-327. doi: 10.5001/omj.2017.61. Abstract OBJECTIVES: Multidrug resistance (MDR) and emergence of extended-spectrum β-lactamases (ESBLs) among uropathogenic Escherichia coli have been reported worldwide, but there was no information on the detection of bla(CTX-M-15) in major teaching hospitals in Libya. …

Detection of CTX-M-15 Among Uropathogenic Escherichia coli Isolated from Five Major Hospitals in Tripoli, Libya Read More »

. . Boutrid N, Melki S, Rahmoune H, Ben Abdelaziz A. . Tunis Med. 2020 Mar;98(3):175-190. Abstract INTRODUCTION: Mortality, particularly at younger ages, is a key measure of population health. AIM: To describe under 5 children mortality trends and its related factors in the Great Maghreb countries over the last three decades 1994-2019. METHODS: We …

Under 5 Child Mortality in the Maghreb countries Read More »

. . Khashkhosha HK, Elhadi M. . Med Hypotheses. 2020 Oct;143:110066. doi: 10.1016/j.mehy.2020.110066. Epub 2020 Jul 1. Abstract The COVID-19 pandemic has not spared any continent. The disease has affected more than 7,500,000 individuals globally and killed approximately 450,000 individuals. The disease is caused by a very small virus named severe acute respiratory syndrome coronavirus …

A hypothesis on the role of the human immune system in covid-19 Read More »

. . Elmontsri M, Banarsee R, Majeed A. . BMJ Open. 2017 Jul 2;7(6):e014770. doi: 10.1136/bmjopen-2016-014770. Abstract INTRODUCTION: Patient safety is a global public health problem. Estimates and size of the problem of patient safety in low-income and developing countries are scarce. A systems approach is needed for ensuring that patients are protected from harm …

Key priority areas for patient safety improvement strategy in Libya: a protocol for a modified Delphi study Read More »

. . Daw MA, El-Bouzedi AH, Ahmed MO. . Front Public Health. 2021 Jun 14;9:628211. doi: 10.3389/fpubh.2021.628211. 2021. Abstract COVID-19 is a global pandemic that has affected all aspects of life. Understanding its geographical and epidemiological characteristics has become particularly important in controlling the spread of the pandemic. Such studies are lacking in North African …

The Epidemiological and Spatiotemporal Characteristics of the 2019 Novel Coronavirus Disease (COVID-19) in Libya Read More »

. . Mirzoyan L, Berendes S, Jeffery C, Thomson J, Ben Othman H, Danon L, Turki AA, Saffialden R, Valadez JJ. . J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):577-83. doi: 10.1097/QAI.0b013e318284714a. Abstract BACKGROUND: Libya had one of the world’s largest nosocomial HIV outbreaks in the late 1990 s leading to the detention of 6 …

New evidence on the HIV epidemic in Libya: why countries must implement prevention programs among people who inject drugs Read More »

. . Bodalal Z, Bendardaf R, Ambarek M, Nagelkerke N. . Libyan J Med. 2015 Feb 10;10:26930. doi: 10.3402/ljm.v10.26930. 2015. Abstract BACKGROUND: Road traffic injuries (RTIs) are a major public health concern in Libya. In the light of the armed conflict in Libya that broke out on February 2011 and the subsequent instability, the rate …

Impact of the 2011 Libyan conflict on road traffic injuries in Benghazi, Libya Read More »

. . Eldaghayes I, Dayhum A, Kammon A, Sharif M, Ferrari G, Bartels C, Sumption K, King DP, Grazioli S, Brocchi E. . Open Vet J. 2017;7(1):1-11. doi: 10.4314/ovj.v7i1.1. Epub 2017 Jan 13. Abstract Sporadic outbreaks of foot-and-mouth disease (FMD) have occurred in Libya for almost fifty years. During the spring of 2013, a countrywide …

Exploiting serological data to understand the epidemiology of foot-and-mouth disease virus serotypes circulating in Libya Read More »

. . Elhadi M, Momen AA, Alsoufi A, Msherghi A, Zaid A, Ali Senussi Abdulhadi OM, Elhadi A, Omar Elfandi HB, Salam Alshammam AM, Hadreiez AK, Abdulsalam Elbulati MT, Almahdi El Bibas MA, Mohamed Benaser AA, Rajab Zendah MM, Mohammed Makhlouf AA, Abdulhamed MA, BenSuleiman MM, Amer AO, Shaban MAA, Faraj HA. . Travel Med …

Epidemiological and clinical presentations of hospitalized COVID-19 patients in Libya: An initial report from Africa Read More »

. . Madour A, Alkout A, Vanin S. . East Mediterr Health J. 2013 Dec;19(12):990-4. Abstract The hepatitis B virus (HBV) vaccination schedule in Libya follows international recommendations (1st dose at birth, 2nd after 1 month and 3rd after 6 months). This research aimed to evaluate the long-term protection of the HBV immunization programme in …

First evaluation of the serum level of anti-hepatitis B surface antigen after vaccination in Libya Read More »